These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7845748)

  • 21. Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine.
    Nirmal S; Cherian T; Samuel BU; Rajasingh J; Raghupathy P; John TJ
    Vaccine; 1998; 16(9-10):928-31. PubMed ID: 9682339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody persistence after primary immunization with trivalent oral poliovirus vaccine.
    Krugman RD; Hardy GE; Sellers C; Parkman PD; Witte JJ; Meyer BC; Meyer HM
    Pediatrics; 1977 Jul; 60(1):80-2. PubMed ID: 195265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroimmunity to poliomyelitis in hospital personnel.
    Tang RB; Wang HC; Lee SJ; Chang TK; Hwang B
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Nov; 17(4):188-92. PubMed ID: 6099791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn.
    Blanchard-Rohner G; Meier S; Bel M; Combescure C; Othenin-Girard V; Swali RA; Martinez de Tejada B; Siegrist CA
    Pediatr Infect Dis J; 2013 Dec; 32(12):1374-80. PubMed ID: 24569309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of oral poliomyelitis vaccine (OPV) against variants of wild poliovirus type 3.
    Böthig B; Danes L; Dittmann S
    Bull World Health Organ; 1990; 68(5):597-600. PubMed ID: 1963118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplacental antibodies. Part III: Maternal antibodies against polioviruses, M. parotitidis and M. parainfluenzae.
    Celko A; Burianová B; Fedová D; Koza J; Zikmundová V; Zikmund V; Stríbrný J
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(2):193-9. PubMed ID: 2991367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
    Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico.
    Dayan GH; Thorley M; Yamamura Y; Rodríguez N; McLaughlin S; Torres LM; Seda A; Carbia M; Alexander LN; Caceres V; Pallansch MA
    J Infect Dis; 2007 Jan; 195(1):12-20. PubMed ID: 17152004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response to three doses of standard and double dose of trivalent oral polio vaccine.
    Agarwal A; Sharma D; Kumari S; Khare S
    Indian Pediatr; 1991 Oct; 28(10):1141-5. PubMed ID: 1665840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.
    Qiu J; Yang Y; Huang L; Wang L; Jiang Z; Gong J; Wang W; Wang H; Guo S; Li C; Wei S; Mo Z; Xia J
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28362135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diarrhea on the humoral response to oral polio vaccination.
    Myaux JA; Unicomb L; Besser RE; Modlin JF; Uzma A; Islam AM; Santosham M
    Pediatr Infect Dis J; 1996 Mar; 15(3):204-9. PubMed ID: 8852907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparing the immunogenicity and safety of sequential inoculation of sIPV followed by bOPV (Ⅰ+Ⅲ) in different dosage forms].
    Ye H; Huang T; Ying ZF; Li GL; Che YC; Zhao ZM; Wang JF; Yang XL; Shi L; Jiang RJ; Liu XC; Mo ZJ; Li CG; Yang JS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):43-49. PubMed ID: 29334707
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody titers against vaccine and contemporary wild poliovirus type 1 in children immunized with IPV+OPV and young adults immunized with OPV.
    Lukashev AN; Yarmolskaya MS; Shumilina EY; Sychev DA; Kozlovskaya LI
    Virus Res; 2016 Feb; 213():162-164. PubMed ID: 26657881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-lasting poliovirus-neutralizing antibodies among Argentinean population immunized with four or five oral polio vaccine doses 1 month to 19 years previously.
    Nates SV; Martinez LC; Barril PA; Ferreyra LJ; Giordano MO; Masachessi G; Isa MB
    Viral Immunol; 2007; 20(1):3-10. PubMed ID: 17425416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules.
    Parent du Châtelet I; Merchant AT; Fisher-Hoch S; Luby SP; Plotkin SA; Moatter T; Agboatwalla M; McCormick JB
    Vaccine; 2003 Apr; 21(15):1710-8. PubMed ID: 12639494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neutralizing antibodies to poliovirus in the sera of newborn infants before and after mass immunization of the Brazilian population from 0 to 5. São Paulo, Brazil (1980)].
    Hutzler RU; Fujita M; Waldman EA; Ayub MA; Ferrari FL; Pinto PR; Cury PC; Kim JS; Matheus JG
    Rev Inst Med Trop Sao Paulo; 1984; 26(2):78-82. PubMed ID: 6089300
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan.
    Reichler MR; Kharabsheh S; Rhodes P; Otoum H; Bloch S; Majid MA; Pallansch MA; Patriarca PA; Cochi SL
    J Infect Dis; 1997 Feb; 175 Suppl 1():S198-204. PubMed ID: 9203717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines.
    McBean AM; Thoms ML; Albrecht P; Cuthie JC; Bernier R
    Am J Epidemiol; 1988 Sep; 128(3):615-28. PubMed ID: 2843039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.